James Daniel Byrne, MD
Maternal & Fetal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Byrne’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G74780 · Current
Licensed to practise in California · since 1992 · expires 2028-03-31 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$23,846 in 2024
Medicaid paid $23,846 for 1,284 billed services this clinician did in 2024, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 25 | $13,198 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 313 | $3,926 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 466 | $3,136 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 185 | $1,582 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 87 | $954 |
| FETAL NON-STRESS TEST | 150 | $629 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 12 | $421 |
| Medication list documented in medical record (COA) | 46 | $0 |
| 2024 | 1,284 | 8 | 72 | $23,846 |
| 2023 | 1,803 | 10 | 71 | $97,563 |
| 2022 | 1,467 | 16 | 58 | $98,996 |
| 2021 | 859 | 7 | 42 | $38,325 |
| 2020 | 1,261 | 8 | 30 | $359,451 |
| 2019 | 1,654 | 7 | 35 | $442,319 |
| 2018 | 2,631 | 9 | 83 | $709,907 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 175 | $87,127 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 361 | $4,201 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 488 | $3,116 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 216 | $1,126 |
| FETAL NON-STRESS TEST | 287 | $834 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 75 | $518 |
| Return visit (30+ min) | 52 | $236 |
| Short return visit (20+ min) | 125 | $217 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 12 | $94 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 12 | $94 |
2022
| Clinic visit/encounter, all-inclusive | 176 | $87,546 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 280 | $4,488 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 317 | $2,734 |
| Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis | 32 | $1,044 |
| Return visit (30+ min) | 164 | $915 |
| FETAL NON-STRESS TEST | 151 | $597 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 75 | $565 |
| Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result | 58 | $552 |
| Short return visit (20+ min) | 24 | $132 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 20 | $122 |
| Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision | 69 | $106 |
| Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique | 20 | $75 |
2021
| Clinic visit/encounter, all-inclusive | 59 | $30,013 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 245 | $3,181 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 316 | $2,846 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 109 | $1,530 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 50 | $513 |
| FETAL NON-STRESS TEST | 64 | $218 |
| Short return visit (20+ min) | 16 | $26 |
2020
| Clinic visit/encounter, all-inclusive | 846 | $354,229 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 158 | $2,839 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 137 | $1,221 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 45 | $544 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 12 | $322 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 17 | $186 |
| FETAL NON-STRESS TEST | 20 | $110 |
| Short return visit (20+ min) | 26 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,084 | $437,657 |
| Return visit (30+ min) | 201 | $1,661 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 103 | $1,130 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 158 | $990 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 28 | $554 |
| FETAL NON-STRESS TEST | 63 | $189 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 17 | $138 |
2018
| Clinic visit/encounter, all-inclusive | 1,743 | $703,630 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 182 | $2,094 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 228 | $1,170 |
| Return visit (30+ min) | 72 | $848 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 65 | $714 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 102 | $627 |
| FETAL NON-STRESS TEST | 124 | $406 |
| OFF/OP EST MAY X REQ PHY/QHP | 99 | $366 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 16 | $52 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 13 Part D prescriptions in 2015. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2015 | 13 | None | 0% (0) | None | $266 |
| 2014 | 29 | None | 0% (0) | None | $2,378 |
| 2013 | 33 | None | 0% (0) | None | $625 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2014: 1 drug
| Venlafaxine Hcl Er | 11 | $156 | $14 |
2013: 1 drug
| Sertraline | 12 | $154 | $13 |
Money from drug and device companies
$14 in 2022
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $14 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2022-02-14 | Ozempic | $14 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1831134097
- Licence
- CA G74780California G74780: Current · expires 2028-03-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G747800
- Taxonomy
- Federal specialty code 207VM0101X (207VM0101X); Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 751 S Bascom Ave, Ob Gyn Dept, San Jose, CA, 95128
- NPI first listed
- 2006-06-19
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.